Skandinaviska Enskilda Banken (SEB)’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12,400
Closed -$759K 909
2023
Q4
$759K Buy
+12,400
New +$736K ﹤0.01% 731
2021
Q3
Sell
-81,800
Closed -$4.26M 1078
2021
Q2
$4.26M Hold
81,800
0.03% 452
2021
Q1
$3.61M Hold
81,800
0.02% 478
2020
Q4
$2.85M Buy
81,800
+25,500
+45% +$906K 0.02% 519
2020
Q3
$2.05M Buy
56,300
+54,300
+2,715% +$2.02M 0.02% 565
2020
Q2
$75K Buy
+2,000
New +$80K ﹤0.01% 975

Other funds holding PBH

Skandinaviska Enskilda Banken (SEB)'s PBH Position: Q1 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Prestige Consumer Healthcare (PBH) in Q1 2024, closing a stake of 12,400 shares — an estimated $759K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in PBH in Q2 2020 and held it in 6 quarters. The position peaked at $4.26M in Q2 2021. 312 funds tracked by Wall St. Rank hold PBH as of Q1 2024.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Prestige Consumer Healthcare position as of Q1 2024 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 12,400 Prestige Consumer Healthcare shares in Q1 2024, an estimated $759K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Prestige Consumer Healthcare in Q2 2020 and held it in 6 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Prestige Consumer Healthcare position peaked at $4.26M in Q2 2021.
  • 312 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2024, filed 13 May 2024.